Genentech hedged early on Avastin
Marc Iskowitz
January 01 2012
FDA commissioner Margaret Hamburg's final decision to rescind Avastin's indication for metastatic breast cancer came in November. But ad spending ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Your message:
The e-mail address(es) that you supply to use this service will only be used to send the requested article.